Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paraskevi Panagopoulou is active.

Publication


Featured researches published by Paraskevi Panagopoulou.


Cellular and Molecular Life Sciences | 2006

Brucella as a biological weapon.

Georgios Pappas; Paraskevi Panagopoulou; Leonidas Christou; Nikolaos Akritidis

Abstract.Brucella has traditionally been considered a biological weapon. It was the subject of extensive offensive research in the past, and still belongs to category B pathogens on most lists. Its propensity for airborne transmission and induction of chronic debilitating disease requiring combined antibiotic regimens for treatment, its abundance around the world and its vague clinical characteristics defying rapid clinical diagnosis are some of the characteristics that apply to the pathogen’s weapons potential. Yet minimal mortality, availability of treatment options, protracted inoculation period and the emergence of new, more virulent potential weapons means that its inclusion among agents of bioterrorism is nowadays mainly of historical significance. Nevertheless, in the interest of literacy and of avoiding panic, physicians and the public both should be aware of the most common zoonosis worldwide.


Pediatric Blood & Cancer | 2012

In vitro fertilization and risk of childhood leukemia in Greece and Sweden.

Eleni Petridou; Theodoros N. Sergentanis; Paraskevi Panagopoulou; Maria Moschovi; Sophia Polychronopoulou; Margarita Baka; Apostolos Pourtsidis; Fani Athanassiadou; Maria Kalmanti; Vasiliki Sidi; Nick Dessypris; Constantine Frangakis; Ioannis L. Matsoukis; Christodoulos Stefanadis; Alkistis Skalkidou; Olof Stephansson; Hans-Olov Adami; Helle Kieler

Cancer risk in children born after in vitro fertilization (IVF) remains largely unknown. We aimed to investigate risk of leukemia and lymphoma following IVF using two nationwide datasets.


Infection Control and Hospital Epidemiology | 2007

Filamentous Fungi in a Tertiary Care Hospital: Environmental Surveillance and Susceptibility to Antifungal Drugs

Paraskevi Panagopoulou; Joanna Filioti; Evangelia Farmaki; Avgi Maloukou; Emmanuel Roilides

OBJECTIVE To evaluate filamentous fungi with respect to environmental load and potential drug resistance in a tertiary care teaching hospital. DESIGN Monthly survey in 2 buildings of the hospital during a 12-month period. SETTING Hippokration Hospital in Thessaloniki, Greece. METHODS Air, surface, and tap water sampling was performed in 4 departments with high-risk patients. As sampling sites, the solid-organ transplantation department and the hematology department (in the older building) and the pediatric oncology department and the pediatric intensive care unit (in the newer building) were selected. RESULTS From January to May of 2000, the fungal load in air (FLA) was low, ranging from 0 to 12 colony-forming units (cfu) per m(3) in both buildings. During the summer months, when high temperature and humidity predominate, the FLA increased to 4-56 cfu/m(3). The fungi commonly recovered from culture of air specimens were Aspergillus niger (25.9%), Aspergillus flavus (17.7%), and Aspergillus fumigatus (12.4%). Non-Aspergillus filamentous fungi, such as Zygomycetes and Dematiaceous species, were also recovered. The pediatric intensive care unit had the lowest mean FLA (7.7 cfu/m(3)), compared with the pediatric oncology department (8.7 cfu/m(3)), the solid-organ transplantation department (16.1 cfu/m(3)), and the hematology department (22.6 cfu/m(3)). Environmental surfaces were swabbed, and 62.7% of the swab samples cultured yielded filamentous fungi similar to the fungi recovered from air but with low numbers of colony-forming units. Despite vigorous sampling, culture of tap water yielded no fungi. The increase in FLA observed during the summer coincided with renovation in the building that housed the solid-organ transplantation and hematology departments. All 54 Aspergillus air isolates randomly selected exhibited relatively low minimum inhibitory or effective concentrations for amphotericin B, itraconazole, voriconazole, posaconazole, micafungin, and anidulafungin. CONCLUSION Air and surface fungal loads may vary in different departments of the same hospital, especially during months when the temperature and humidity are high. Environmental Aspergillus isolates are characterized by lack of resistance to clinically important antifungal agents.


Infection | 2003

Femoral Osteomyelitis Due to Aspergillus nidulans in a Patient with Chronic Granulomatous Disease

John Dotis; Paraskevi Panagopoulou; J. Filioti; R. Winn; C. Toptsis; Christos Panteliadis; Emmanuel Roilides

Abstract.13 cases of osteomyelitis caused by Aspergillus nidulans have been previously reported in patients with chronic granulomatous disease (CGD). All of them have been associated with simultaneous pulmonary infection and have had an extremely poor outcome. We report an unusual case of femoral osteomyelitis due to A. nidulans in a 16-year-old male with CGD, without pulmonary involvement. Treatment with liposomal amphotericin B and granulocyte colonystimulating factor as well as extensive surgical debridement followed by prolonged treatment with itraconazole resulted in an excellent clinical response.


Frontiers in Public Health | 2014

The MOBI-Kids study protocol: challenges in assessing childhood and adolescent exposure to electromagnetic fields from wireless telecommunication technologies and possible association with brain tumor risk

Siegal Sadetzki; Chelsea Eastman Langer; Revital Bruchim; Michael Kundi; Franco Merletti; Roel Vermeulen; Hans Kromhout; Ae-Kyoung Lee; Myron Maslanyj; Malcolm Ross Sim; Masao Taki; Joe Wiart; Bruce K. Armstrong; Elizabeth Milne; Geza Benke; Rosa Schattner; Hans-Peter Hutter; Adelheid Woehrer; Daniel Krewski; Charmaine Mohipp; Franco Momoli; Paul Ritvo; John J. Spinelli; Brigitte Lacour; Dominique Delmas; Thomas Remen; Katja Radon; Tobias Weinmann; Swaantje Klostermann; Sabine Heinrich

The rapid increase in mobile phone use in young people has generated concern about possible health effects of exposure to radiofrequency (RF) and extremely low frequency (ELF) electromagnetic fields (EMF). MOBI-Kids, a multinational case–control study, investigates the potential effects of childhood and adolescent exposure to EMF from mobile communications technologies on brain tumor risk in 14 countries. The study, which aims to include approximately 1,000 brain tumor cases aged 10–24 years and two individually matched controls for each case, follows a common protocol and builds upon the methodological experience of the INTERPHONE study. The design and conduct of a study on EMF exposure and brain tumor risk in young people in a large number of countries is complex and poses methodological challenges. This manuscript discusses the design of MOBI-Kids and describes the challenges and approaches chosen to address them, including: (1) the choice of controls operated for suspected appendicitis, to reduce potential selection bias related to low response rates among population controls; (2) investigating a young study population spanning a relatively wide age range; (3) conducting a large, multinational epidemiological study, while adhering to increasingly stricter ethics requirements; (4) investigating a rare and potentially fatal disease; and (5) assessing exposure to EMF from communication technologies. Our experience in thus far developing and implementing the study protocol indicates that MOBI-Kids is feasible and will generate results that will contribute to the understanding of potential brain tumor risks associated with use of mobile phones and other wireless communications technologies among young people.


Journal of Pediatric Gastroenterology and Nutrition | 2008

Adiponectin and Insulin Resistance in Childhood Obesity

Paraskevi Panagopoulou; Assimina Galli-Tsinopoulou; Alexandra Fleva; E. Pavlitou-Tsiontsi; Norma Vavatsi-Christaki; Sanda Nousia-Arvanitakis

Objectives: To measure adiponectin serum levels in Greek children and adolescents and correlate them with body fat and insulin resistance. Patients and Methods: Forty-six obese prepubertal children (19 M, 27 F) and 34 obese adolescents (17 M, 17 F) ages 9.33 ± 1.57 and 13.6 ± 1.42 years, respectively, and 43 matched control individuals were studied. Body mass index standard deviation score and percent body fat were measured by bioelectric impedance analysis. Fasting indices of insulin resistance (HOMA-IR and fasting glucose-to-insulin ratio) were calculated for all participants. Indices of insulin resistance derived from oral glucose tolerance tests were estimated in obese participants. Adiponectin was measured by enzyme-linked immunosorbent assay. Results: (Mean ± SD): Adiponectin serum levels were significantly lower in obese participants than in nonobese participants (8.11 ± 3.80 vs 11.81 ± 4.98 μg/mL, P < 0.001), in obese children than in nonobese children (8.86 ± 3.86 vs 13.08 ± 5.48 μg/mL, P < 0.001), in obese adolescents than in nonobese adolescents (7.04 ± 3.43 vs 10.47 ± 4.10 μg/mL, P = 0.002), and in obese adolescent boys than in obese adolescent girls (5.87 ± 3.52 vs 8.31 ± 3.16 μg/mL, P = 0.042). There were significant correlations between adiponectin and age, body mass index, body mass index standard deviation score, homeostasis model assessment for insulin resistance, and fasting glucose-to-insulin ratio. Adiponectin correlated with percent body fat after adjustment for sex. Adiponectin correlated significantly with several indices of insulin resistance, such as the areas under the curves for glucose and insulin, whole-body insulin sensitivity index, glucose120′, and insulin30′, in obese participants. Conclusions: Adiponectin was significantly lower in obese participants than in nonobese participants in general, and it correlated significantly with fasting indices of insulin resistance and with indices derived from oral glucose tolerance tests. It is worthwhile to further investigate the option of applying a simple measurement of serum adiponectin as a screening tool before applying more time-consuming techniques in young obese individuals.


Infectious Disease Clinics of North America | 2003

Immunomodulation of invasive fungal infections.

Emmanuel Roilides; Caron A. Lyman; Paraskevi Panagopoulou; Stephen J. Chanock

Genetic and acquired (disease- or therapy- related) host immune factors increase the risk for IFIs. In addition to antifungal drug therapy, modulation of host defenses by the use of HGFs and IFN-gamma has been supported by extensive in vitro and in vivo preclinical data. Clinical studies on the prevention or the adjunctive therapy of IFIs in combination with antifungal agents are limited, however, and do not allow specific recommendations for their cost-effective use in most of the immunodeficient settings. There is an urgent need to push forward with well-structured, randomized clinical trials to determine optimal dose, duration, and timing for different combinations of immunotherapy and antifungal agents in high-risk patients.


International Journal of Cancer | 2011

Maternal smoking during pregnancy and childhood lymphoma: a meta-analysis.

Constantine N. Antonopoulos; Theodoros N. Sergentanis; Charalampia Papadopoulou; Elisabeth Andrie; Nick Dessypris; Paraskevi Panagopoulou; Sophia Polychronopoulou; Apostolos Pourtsidis; Fani Athanasiadou-Piperopoulou; Maria Kalmanti; Maria Moschovi; Eleni Petridou

Results from epidemiological studies exploring the association between childhood lymphoma and maternal smoking during pregnancy have been contradictory. This meta‐analysis included all published cohort (n = 2) and case–control (n = 10) articles; among the latter, the data of the Greek Nationwide Registry for Childhood Hematological Malignancies study were updated to include all recently available cases (‐2008). Odds ratios (ORs), relative risks and hazard ratios were appropriately pooled in three separate analyses concerning non‐Hodgkin lymphoma (NHL, n = 1,072 cases), Hodgkin lymphoma (HL, n = 538 cases) and any lymphoma (n = 1,591 cases), according to data availability in the included studies. An additional metaregression analysis was conducted to explore dose–response relationships. A statistically significant association between maternal smoking (any vs. no) during pregnancy and risk for childhood NHL was observed (OR = 1.22, 95% confidence interval, CI: 1.03–1.45, fixed effects model), whereas the risk for childhood HL was not statistically significant (OR = 0.90, 95% CI: 0.66–1.21, fixed effects model). The analysis on any lymphoma did not reach statistical significance (OR = 1.10, 95% CI = 0.96–1.27, fixed effects model), possibly because of the case‐mix of NHL to HL. No dose–response association was revealed in the metaregression analysis. In conclusion, this meta‐analysis points to a modest increase in the risk for childhood NHL, but not HL, among children born by mothers smoking during pregnancy. Further investigation of dose–response phenomena in the NHL association, however, warrants accumulation of additional data.


Journal of Pediatric Gastroenterology and Nutrition | 2010

Carcinoid Tumors of the Appendix in Children: Experience From a Tertiary Center in Northern Greece

Emmanouil Hatzipantelis; Paraskevi Panagopoulou; Vasiliki Sidi-Fragandrea; Ioanna Fragandrea; Dimitrios E. Koliouskas

Background and Objective: Carcinoid tumors of the appendix are rare in childhood and usually have a benign clinical course. Their incidence in appendectomy specimens ranges from 0.1% to 0.9%. The aim of the study was to report the frequency, clinical presentation, tumor characteristics, and outcome of children with appendiceal carcinoid treated in a pediatric oncology department. Patients and Methods: All of the cases referred during a 19-year period (1990–2008) were studied retrospectively. Demographics, clinical presentation, tumor characteristics, and follow-up results were recorded. Results: Among 839 admissions, 19 patients (9 boys) with appendiceal carcinoid were identified during the study period. Their median age was 10.5 years (range 4.5–13.2 years). In all of the cases, diagnosis was established after appendectomy. The mean tumor diameter was 4.55 (±3.45) mm (range 1–15 mm). Concomitant appendicitis was diagnosed in 12 patients. In 18 children tumor size was ≤10 mm and did not infiltrate surrounding tissues. In 1 patient the size was 15 mm and a microscopic rupture of the appendix with infiltration of the surrounding fat was present. All of the tumors were located at the tip of the appendix and were of the classic histological type. Staging and follow-up consisted of abdominal ultrasound, chest and abdominal computed tomography scans, 99Tc bone scan, urine 5-hydroxylindoloacetic acid levels, and 111In octreotide scan. No patient had metastases requiring further therapeutic interventions. No relapses or other neoplasms occurred during a median follow-up period of 45 months (range 6–118 months). Conclusions: Carcinoid tumors of the appendix in children are rare. Long-term follow-up revealed that a good prognosis is possible provided they are diagnosed and surgically removed at an early stage.


Melanoma Research | 2011

Insulin resistance in relation to melanoma risk.

Antonios G. Antoniadis; Eleni Petridou; Constantine N. Antonopoulos; Nick Dessypris; Paraskevi Panagopoulou; John P. Chamberland; Hans-Olov Adami; Helen Gogas; Christos S. Mantzoros

Obesity, deregulation of adipocytokines, and insulin resistance are interrelated and have been implicated in carcinogenesis. In search of novel risk factors for melanoma, we explored the association of this disease with insulin resistance in a small size, case–control study. Homeostasis Model Assessment for Insulin Resistance (HOMA-IR), serum leptin, and adiponectin levels were determined in 55 patients with incident melanoma and 165 age-matched and sex-matched controls. Odds ratios were derived after adjusting for skin type, medical history, sociodemographic, lifestyle, and anthropometric parameters. Among the controls, HOMA-IR correlated positively with BMI (r=0.34; P=0.0001), waist-to-hip ratio (r=0.20; P=0.01) and negatively with serum adiponectin (r=−0.21; P=0.006), whereas the correlation with leptin was essentially null (r=0.09; P=0.27). The mean HOMA-IR was approximately 1.5 times higher in cases than in controls (P=0.05). The established positive association of melanoma with skin type was evident in multiple logistic regression models and so was the association with increasing HOMA-IR quintile (odds ratio for the fifth quintile=3.68; 95% confidence intervals 1.15–11.79, P=0.02). The latter persisted after adjustment for anthropometric variables and adiponectin but was attenuated when leptin was introduced in the model. These findings point to insulin resistance as a potentially independent risk factor for melanoma and need to be confirmed by future larger studies, ideally allowing the control of the directionality of the association.

Collaboration


Dive into the Paraskevi Panagopoulou's collaboration.

Top Co-Authors

Avatar

Sanda Nousia-Arvanitakis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Nick Dessypris

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Eleni Petridou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

Maria Fotoulaki

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Maria Moschovi

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Assimina Galli-Tsinopoulou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Joana Bastos

Instituto Português de Oncologia Francisco Gentil

View shared research outputs
Researchain Logo
Decentralizing Knowledge